NY AG James Announces Enforcement Action on Health Plan Vendor for Widespread “Ghost Networks” Blocking Patient Access for Necessary Treatment
Navigating an Inaccurate Provider Directory

Click to Enlarge

This week, New York Attorney General Letitia James announced two settlements with Carelon Behavioral Health, Inc. (Carelon) after two Office of the Attorney General (OAG) investigations found that Carelon misled New Yorkers searching for mental health care by directing them to providers who were unavailable and improperly denied coverage for substance use disorder treatment. Carelon administers behavioral health benefits for several health plans, including Emblem, Anthem Blue Cross Blue Shield, Independent Health, and the Empire Plan, the health plan for state and local government employees. Under the settlements, Carelon will pay $2.35 million in penalties, fees, and costs, provide up to $8 million in restitution to eligible members who paid out-of-pocket for out-of-network mental health care, repay other eligible members for out-of-pocket payments for bills denied by Carelon, and overhaul its provider directories and substance use disorder coverage reviews. Eligible members can seek reimbursement for care received as early as January 1, 2020.

Carelon is responsible for the mental health and substance use disorder coverage of more than four million New Yorkers across a variety of health plans. Through two investigations, OAG found that Carelon violated a 2015 agreement with OAG that required it to, among other things, maintain an accurate provider directory, ensure an adequate provider network, and only use approved criteria when reviewing requests for substance use disorder treatment.

Ghost Network Investigation. The OAG’s first investigation found through a secret shopper study, that Carelon’s online provider directories contained many errors, including listings for providers who were unreachable, no longer practicing, not accepting new patients, or not actually in-network. The consequences for New Yorkers were significant. Learn more details from AG James’ report about the enormous impact to patients, particularly those living with mental health and substance abuse disorders. 

Lastly, to improve access to mental health care, Carelon must develop a plan to recruit and keep behavioral health providers, reduce administrative burdens, and invest in recruiting child and adolescent psychiatrists and psychiatric nurse practitioners. An independent monitor will audit Carelon’s provider directories, appointment availability, out-of-network use, and behavioral health reimbursement rates and network size compared with medical care, and report to OAG every six months.

Substance Use Coverage Denial Investigation. The OAG’s second investigation examined how Carelon decides whether to cover addiction treatment. Going forward, Carelon must use only OASAS-approved medical necessity criteria and review each member’s full case file, including their diagnosis, symptoms, treatment goals, substance use history, co-occurring conditions, and the risks of stopping treatment. Carelon may deny coverage only when treatment does not meet OASAS standards. The company is also banned from minimizing withdrawal symptoms, requiring patients to fail at a lower level of care before approving a higher one, or requiring proof that a patient poses a risk of serious harm to themselves or others.